Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
75
1
1

Year Published

2021
2021
2022
2022

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 61 publications
(78 citation statements)
references
References 28 publications
1
75
1
1
Order By: Relevance
“…No additional studies were found after screening the references of these articles. Therefore, eight articles evaluating the diagnostic role of 18 F-PSMA-1007 PET/CT in PCa staging were eligible for the systematic review [ 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 ]. The characteristics of these studies selected for the systematic review and including a total number of 369 PCa patients are presented in Table 1 and Table 2 .…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…No additional studies were found after screening the references of these articles. Therefore, eight articles evaluating the diagnostic role of 18 F-PSMA-1007 PET/CT in PCa staging were eligible for the systematic review [ 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 ]. The characteristics of these studies selected for the systematic review and including a total number of 369 PCa patients are presented in Table 1 and Table 2 .…”
Section: Resultsmentioning
confidence: 99%
“…No adverse events due to 18 F-PSMA-1007 administration were reported in the included studies [ 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 ]. Concerning the radiation dosimetry, with an effective dose of 4.4–5.5 mSv for an injected activity of 200–250 MBq, 18 F-PSMA-1007 is similar to other PSMA-targeted PET agents as well as to other 18 F-labelled PET radiopharmaceuticals.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations